Metzger Michael A bought SNDX
February 4, 2026 · Form 4 insider transaction
Metzger Michael A bought 440,000 shares of Syndax Pharmaceuticals, Inc. at $20.43 per share, a transaction worth $8.99M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
440,000
Price
$20.43
Total value
$8.99M
InsiderMetzger Michael A
RoleOfficer, Director
SecurityStock Options (Right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 4, 2026
Filing dateFebruary 6, 2026
Shares owned after440,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/48th of the shares subject to the option shall vest monthly over a four-year period.